Sign in to continue:

Thursday, April 16th, 2026

CaliberCos Inc. Reduces Corporate Debt by $3.4 Million in Latest Debt Reduction Strategy Announcement

CaliberCos Inc. Announces Significant Progress in Corporate Debt Reduction Strategy

SCOTTSDALE, AZ, April 14, 2026 – CaliberCos Inc. (NASDAQ: CWD), a diversified real estate and digital asset management platform, announced today notable advancements in its ongoing corporate debt reduction strategy. The company revealed that it has successfully completed the second round of its Noteholder Conversion Program, effectively reducing its corporate debt by an additional \$3.4 million.

Key Highlights of the Announcement

  • Conversion of Unsecured Corporate Notes:
    – Approximately \$1.9 million of unsecured corporate notes were converted into Caliber’s Class A Common Stock.
    – Around \$1.5 million of unsecured corporate notes were converted into the newly authorized Series AAA Convertible Preferred Stock.
  • New Series AAA Convertible Preferred Stock:

    • The Board of Directors has authorized the creation of Series AAA Convertible Preferred Stock, specifically aimed at facilitating further debt reduction.
    • This preferred stock offers a 12% annual cumulative dividend and is convertible into Caliber Class A Common Shares in three distinct tranches:

      • First third at \$2.50 per share
      • Second third at \$3.50 per share
      • Final third at \$4.50 per share
    • The offer was made to holders of Caliber’s unsecured corporate notes, giving them an option to convert into this new instrument on a voluntary basis.

Management Commentary

Chris Loeffler, Chief Executive Officer of Caliber, emphasized the importance of this initiative: “Reducing corporate debt remains a priority for us as we continue to strengthen the foundation of the business. We’ve made meaningful progress through this program, and we intend to continue executing in a disciplined way to improve our balance sheet and reduce interest expense as we advance toward Caliber’s stated goal of adjusted EBITDA and net operating income profitability in 2026.”

Other Important Details for Shareholders and Investors

  • Resale Registration Statement: The company filed a resale registration statement related to these transactions on April 13, 2026, which may be relevant for future liquidity and trading considerations.
  • Potential Share Price Impact:

    • The conversion of debt into equity and preferred stock, particularly with the attractive terms of the Series AAA Convertible Preferred Stock, could have a material impact on the company’s capital structure, reducing interest expenses and improving the balance sheet.
    • The dilution effect from the conversion of notes into common and preferred shares should be considered, as it may affect future earnings per share and share value.
    • The company’s explicit target for profitability on an adjusted EBITDA and net operating income basis by 2026 could be positively received by the market, assuming continued execution.
  • Strategic Focus on Digital Assets: Caliber continues to implement blockchain and tokenization strategies across its investment platform, investing in assets such as LINK (the token underlying Chainlink) to enhance asset financing, ownership, and accessibility.

Forward-Looking Statements and Risks

The company’s statements include “forward-looking statements” subject to substantial risks and uncertainties, including but not limited to assumptions about future events, market conditions, and execution of corporate strategies. Actual results may differ materially from those expressed or implied due to various factors outlined in Caliber’s filings with the SEC, including the “Risk Factors” section of the final prospectus for its public offering.

Contact Information

For more information, investors are encouraged to contact Caliber Investor Relations:
Ilya Grozovsky
Phone: +1 480-214-1915
Email: [email protected]


Disclaimer: This article is for informational purposes only and does not constitute investment advice. Investors should perform their own due diligence and consult with professional advisors before making investment decisions. The information is based on public filings and statements as of April 14, 2026, and may not be updated for subsequent developments.

View CaliberCos Inc. Historical chart here



Community Health Systems to Sell Four Arkansas Hospitals to Freeman Health System for $112 Million

Community Health Systems Announces Sale of Four Arkansas Hos...

IDEAYA Biosciences Announces Phase 2/3 Clinical Update for Darovasertib Combination in OptimUM-02 Trial

IDEAYA Biosciences, Inc. Files 8-K: Key Developments and Ins...

   Ad